GLP-1 vs Wegovy: What's the Real Difference

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, belongs to a class of medications called GLP-1 receptor agonists that signal the brain to reduce hunger and slow stomach emptying. While Wegovy dominates the weight loss conversation, many people don't realize that GLP-1 therapy encompasses multiple delivery methods and brands—and that access no longer requires a brand-name prescription or insurance coverage. Understanding these distinctions helps you find the right treatment option for your health goals and budget.

What Is GLP-1 and How Does It Work?

GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone your body produces when you eat. This hormone tells your brain that you're satisfied, slows the rate at which food leaves your stomach, and helps regulate blood sugar levels. Medications that mimic GLP-1 trigger the same receptors in your brain and digestive system, creating a powerful signal of fullness that persists even when your stomach is genuinely empty. Clinical trials show that people using GLP-1 receptor agonists consume an average of 20% fewer calories without consciously restricting food intake.

The strength of GLP-1 therapy lies in its dual action: it reduces both the desire to eat and the speed at which hunger returns after meals. This mechanism differs fundamentally from older weight loss drugs that simply boosted metabolism or increased energy. Because GLP-1 works with your body's natural signaling pathways rather than forcing chemical changes, many patients report that weight loss feels more sustainable and less dependent on willpower alone.

Wegovy vs GLP-1 Medications: Key Differences Explained

Wegovy is a brand-name injectable semaglutide manufactured by Novo Nordisk and approved by the FDA specifically for chronic weight management in adults. The term GLP-1, by contrast, refers to the entire class of medications that activate GLP-1 receptors—a category that includes Wegovy, Ozempic (also semaglutide), Mounjaro (tirzepatide), and compounded formulations. Think of it this way: all Wegovy is a GLP-1 medication, but not all GLP-1 medications are Wegovy. The brand name carries marketing costs, distribution markups, and insurance coordination fees that don't exist with other GLP-1 options.

Wegovy's price typically ranges from $900 to $1,400 per month without insurance, while compounded semaglutide through PlexusDx starts at $149 per month. Both contain chemically identical semaglutide, but the compounded version is prepared by licensed 503A pharmacies rather than mass-manufactured in a pharmaceutical facility. The practical difference for patients is significant: one requires insurance approval or substantial out-of-pocket spending, while the other offers immediate access without membership fees or authorization delays.

Injectable vs Oral GLP-1 Options: Which Format Is Right for You?

GLP-1 medications come in two delivery formats: injectables and oral tablets. Injectable semaglutide (PlexusDx Compounded Semaglutide Injection) is administered once weekly using a small pen device, with doses ranging from 0.25 mg to 2.4 mg depending on your response and tolerance. Oral semaglutide (PlexusDx Oral Semaglutide) is taken daily on an empty stomach and typically requires larger doses because the digestive system breaks down some of the medication before absorption. Both formats deliver the same active compound and produce similar weight loss results when dosed appropriately, but they differ in convenience, absorption rates, and individual tolerability.

Patients often prefer injections because they require only one dose per week and typically produce more consistent blood levels of medication throughout the month. Oral formulations appeal to needle-averse individuals and those who want daily control over their therapy. PlexusDx offers both options so your prescriber can select the format that aligns with your preferences, lifestyle, and medical history. Your dose may need to go up as your body adapts, but your price won't—a cost certainty that Wegovy's tiered pricing structure cannot match.

Why Genetic Testing Enhances GLP-1 Outcomes

Not everyone responds to GLP-1 medications at the same rate or to the same degree, which is where the PlexusDx Precision Peptide Genetic Test becomes valuable. This test analyzes 14 metabolic pathways and 150+ genetic insights related to appetite regulation, including variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313). These genetic markers influence how your body's hunger and satiety systems function, which receptors respond best to GLP-1 stimulation, and whether you'll experience optimal weight loss or need dose adjustments earlier in treatment.

By identifying your unique genetic profile, PlexusDx can recommend whether semaglutide, tirzepatide, or a dual-compound approach (GLP-Squared) aligns best with your body's peptide pathways. This personalization accelerates your path to effective dosing, reduces trial-and-error adjustments, and helps prevent wasted time or money on formulations that won't work optimally for your genetic makeup. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment and provides clarity that brand-name Wegovy prescribers cannot offer.

Cost, Access, and the Case for Compounded GLP-1

Wegovy's brand status creates artificial scarcity and high pricing that shifts costs to patients when insurance denies coverage or deductibles are unmet. Compounded GLP-1 medications from licensed 503A pharmacies provide identical active compounds at a fraction of the cost because they bypass middleman markups, insurance coordination overhead, and brand advertising expenses. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization—you simply have a telehealth visit with a licensed prescriber, receive your prescription, and receive your medication shipped directly. HSA and FSA accounts are accepted, making compounded therapy a legitimate medical expense that reduces your tax-advantaged health savings.

The guarantee that your dose may increase while your price stays flat represents a philosophical difference from brand-name weight loss drugs. When you start PlexusDx Compounded Semaglutide Injection at $149 per month, that rate locks in even if your dose escalates to the full 2.4 mg maintenance level. There are no surprise tier upgrades, no insurance prior-authorization delays, and no pressure to stop therapy because of cost creep. This pricing transparency, combined with licensed pharmacy compounding and direct prescriber relationships, explains why thousands of patients choose compounded GLP-1 over Wegovy each month.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide the same as Wegovy?

Yes, compounded semaglutide contains the identical active ingredient as Wegovy—both are semaglutide—but compounded versions are prepared by licensed 503A pharmacies rather than manufactured by pharmaceutical companies. The chemical compound is the same, making them therapeutically equivalent, but the cost and access model are radically different. PlexusDx compounded semaglutide starts at $149/month, while Wegovy typically costs $900–$1,400 without insurance.

What clinical evidence supports GLP-1 therapy for weight loss?

The STEP trials demonstrated that semaglutide produces an average 15% body weight reduction over 68 weeks in patients with obesity, with some individuals losing up to 22% of their starting weight. Tirzepatide (dual GLP-1/GIP agonist) showed even greater results in the SURMOUNT trials, averaging 21% weight loss. These outcomes are sustained when therapy continues, and weight regain typically occurs within months after stopping medication.

Does PlexusDx require insurance to access compounded GLP-1?

No. PlexusDx serves all 50 states with no insurance requirement, no membership fees, and no prior authorization delays. You simply schedule a telehealth appointment, discuss your health history with a prescriber, and receive your prescription filled through a licensed 503A compounding pharmacy. HSA and FSA accounts are eligible for payment.

Are there side effects I should know about with GLP-1 therapy?

The most common side effects are nausea, vomiting, constipation, and diarrhea, especially during dose escalation. These effects typically diminish within 1–2 weeks as your body adapts. Rare but serious risks include pancreatitis, thyroid cancer (in animal studies), and gallbladder issues; discuss personal or family history of these conditions with your prescriber before starting therapy.

How does the PlexusDx Precision Peptide Genetic Test improve my outcomes?

The test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes—key regulators of appetite and GLP-1 responsiveness—across 14 metabolic pathways. Results help your prescriber predict whether you'll respond optimally to semaglutide, tirzepatide, or dual-compound therapy, reducing guesswork and accelerating your path to an effective dose. The $99 test is available as an add-on after your first month of treatment.

Understanding the Difference Between GLP-1 and Wegovy